Finally, our study complements the findings of Stella and coworkers, in which the profile characterized by downregulation of NTPDase 3 and upregulation of CD73 was associated with the late stage of BC [12], a phenomenon also demonstrated in an animal model [13]. This evidence concerns the gene NT5E and breast cancer.